Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShares Repurchased
Ratios

Utah Medical Products (UTMD) Cost of Revenue (2016 - 2025)

Utah Medical Products has reported Cost of Revenue over the past 16 years, most recently at $3.8 million for Q4 2025.

  • Quarterly results put Cost of Revenue at $3.8 million for Q4 2025, up 134.3% from a year ago — trailing twelve months through Dec 2025 was $16.5 million (up 769.42% YoY), and the annual figure for FY2025 was $16.5 million, up 768.96%.
  • Cost of Revenue for Q4 2025 was $3.8 million at Utah Medical Products, down from $4.2 million in the prior quarter.
  • Over the last five years, Cost of Revenue for UTMD hit a ceiling of $5.3 million in Q2 2022 and a floor of -$13.3 million in Q4 2023.
  • Median Cost of Revenue over the past 5 years was $4.4 million (2021), compared with a mean of $2.1 million.
  • Biggest five-year swings in Cost of Revenue: skyrocketed 144.01% in 2022 and later tumbled 352.83% in 2023.
  • Utah Medical Products' Cost of Revenue stood at -$11.9 million in 2021, then skyrocketed by 144.01% to $5.2 million in 2022, then tumbled by 352.83% to -$13.3 million in 2023, then rose by 16.9% to -$11.0 million in 2024, then skyrocketed by 134.3% to $3.8 million in 2025.
  • The last three reported values for Cost of Revenue were $3.8 million (Q4 2025), $4.2 million (Q3 2025), and $4.4 million (Q2 2025) per Business Quant data.